Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice

Neoplasma

Volumn 56, Issue 3, 2009, Pages 259-268

  Kumar, S ^a   Deepak, P ^a   Acharya, A ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

CTL response; Hsp70; Immunization; Pro inflammatory cytokines; Survival

Indexed keywords

HEAT SHOCK PROTEIN 70; TUMOR ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER SURVIVAL; CELL CULTURE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOCOMPETENT CELL; LONGEVITY; LYMPHOMA; MALE; MOUSE; NONHUMAN; TUMOR IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CD4+ T LYMPHOCYTE; EXPERIMENTAL NEOPLASM; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MORTALITY; TUMOR CELL LINE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOKINES; FEMALE; HSP70 HEAT-SHOCK PROTEINS; IMMUNIZATION; LONGEVITY; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67650287309     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_03_259     Document Type: Article

References (47)

1. Manjili MH, Wang XY, Park J et al. Cancer Immunotherapy: Stress proteins and hypothermia. Inst J Hypothermia 2002; 18: 506-520. doi:10.1080/ 02656730110116696 (Pubitemid 35469184)
2. Manjili MH, Wang XY, Park J et al. Immunotherapy of cancer using heat shock proteins. Front Bioscience 2002; 7: d43-d52. doi:10.2741/manjili
3. Manjili MH, Wang XY, MacDonald IJ et al. Cancer Immunotherapy and Heat shock proteins: promise and challenges. Expert Opin Biol Ther 2004; 4: 363-373. doi:10.1517/14712598.4.3.363
4. Facciponte JG, MacDonald IJ, Wang XY et al. Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunol Invest 2005; 34: 325-342. doi:10.1081/
5. Castelli C, Rivoltini L, Rini F et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother 2004; 53: 227-333. doi:10.1007/s00262-003-0481-9 (Pubitemid 38328045)
6. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185-194. doi:10.1038/nri749 (Pubitemid 37328765)
7. Rothman JE. Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells. Cell 1989; 59: 591-601. doi:10.1016/0092-8674(89)90005-6
8. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996; 381: 571-579. doi:10.1038/381571a0
9. Srivastava PK, Das MR. The serologically unique cell surface antigen Zajdela ascitic hepatoma is also its tumorassociated transplantation antigen. Int J Cancer 1984; 33: 417-422. doi:10.1002/ijc.2910330321
10. Srivastava PK, DeLeo AB, Old LJ. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci USA 1986; 83: 3407-3411. doi:10.1073/pnas.83.10.3407
11. Udono H, Srivastava PK. Heat shock protein 70 associated peptides elicits specific cancer immunity. J Exp Med 1993; 178: 1391-1396. doi:10.1084/jem.178. 4.1391 (Pubitemid 23277370)
12. Li Z, Srivastava PK. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 1993; 12: 3143-3151. (Pubitemid 23232745)
13. Arnold D, Faath S, Rammensee H et al. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995; 182: 885-889. doi:10.1084/jem.182.3. 885
14. Srivastava PK. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 1993; 62: 153-177. doi:10.1016/S0065-230X(08)60318-8
15. Palladino MA, Srivastava PK, Oettgen HF et al. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas. Cancer Res 1987; 47: 5074-5079.
16. Feldweg AM, Srivastava PK. Molecular heterogeneity of tumor rejection antigen/heat shock protein GP96. Int J Cancer 1995; 63: 310-314. doi:10.1002/ijc.2910630227
17. Udono H, Levey D, Srivastava PK. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci USA 1994; 91: 3077-3081. doi:10.1073/pnas.91.8.3077 (Pubitemid 24130178)
18. Peng P, Ménoret A, Srivastava PK. Purification of immunogenic heat shock protein 70-peptide complexes by ADPaffinity chromatography. J Immunol Methods 1997; 204: 13-21. doi:10.1016/S0022-1759(97)00017-3 (Pubitemid 27192307)
19. Castellino F, Boucher PE, Eichelberg K, et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility class I antigen presentation via two distinct processing pathways. J Exp Med 2000; 191: 1957-1964. doi:10.1084/jem.191.11.1957 (Pubitemid 30390357)
20. Basu S, Binder RJ, Ramalingam T et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001; 14: 303-313. doi:10.1016/S1074-7613(01)00111X (Pubitemid 32289294)
21. Srivastava PK, Udono H, Blachere N et al. Heat shock proteins transfer peptide during antigen processing and CTL priming. Immunogenetics 1994; 39: 93-98. doi:10.1007/BF00188611 (Pubitemid 23344809)
22. Tamura Y, Peng P, Liu K, Daou M et al. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997; 278: 117-120. doi:10.1126/ Science.278.5335.117 (Pubitemid 27446289)
23. Asea A, Kraeft SK, Kurt-Jones EA et al. Hsp70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6: 435-443. doi:10.1038/74697 (Pubitemid 30208161)
24. Basu S, Suto R, Binder R et al. Heat shock proteins as novel mediators of cytokine secretion by macrophages. Cell Stress & Chaperones 1998; 3: 11-16.
25. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255. doi:10.1038/15200 (Pubitemid 29535601)
26. Basu S, Binder RJ, Suto R Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the Fib pathway. Int Immunol 2000; 12: 1539-1546. doi:10.1093/ intimm/12.11.1539
27. Kumar S, Deepak P, Acharya A. Hsp70 induces Th1 polarization through tumor-associated macrophages in a T-cell lymphoma. Neoplasma 2007; 54: 113-122.
28. Burke F, Ralf M, Negus R, Balkwill FA. A cytokine profile of normal and malignant ovary. Cytokine 1996; 8: 578-585. doi:10.1006/cyto.1996.0077 (Pubitemid 26294548)
29. Milliken D, Scotton C, Raju S e et al. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res 2002; 8: 1108-1114.
30. Sato K, Torimoto Y, Tamura Y et at. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 2001; 98: 1852-1857. doi:10.1182/blood.V98.6.1852
31. Tschopp J, Nabhplz M. Perforin-mediated target cell lysis by cytotoxic T-lymphocytes. Ann Rev Immunol 1990; 8: 279-302. doi:10.1146/annurev.iy.08. 040190.001431 (Pubitemid 20135629)
32. Koh J, Kubota T, Koyama T, Migita T et al. Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo. Breast Cancer 2000; 10: 260-267. doi:10.1007/BF02966727
33. Camps J, About I. Cytotoxicity testing of endodontic sealers: a new method. J Endod 2003; 29: 583-586. doi:10.1097/000 04770200309000-00010 (Pubitemid 38658316)
34. Udono H, Srivastava PK. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J Immunol 1994; 152: 5398-5403. (Pubitemid 24152988)
35. Blachere NE, Udono H, Janetzki S, et al. Heat shock protein vaccines against cancer. J Immunother Emphasis Tumor Immunol 1993; 14: 352-356. (Pubitemid 23322757)
36. Tiwari RK et al. Cancer derived purified heat shock protein, gp96, elicits protective immunity in a rat prostate cancer model. Proc. Annu. Meet. Am. Assoc. Cancer Res. 1996; 37: 475.
37. Blachere NE, Zihai li, chandawarkar rY et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptidespecific cytotoxic T-lymphocytes response and tumor immunity. J Exp Med 1997; 186: 1315-1322. doi:10.1084/jem.186.8.1315
38. Faure O, Graff-dubois s, bretaudeau L et al. Inducible Hsp70 as target of anticancer immunotherapy: identification of HLA-A* 0202-restricted epitopes. Int J Cancer 2004; 8: 657-665.
39. Moroi Y, Mayhew M, Trcka J et al. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein70. Proc Natl Acad Sci USA 2000; 97: 3485-3490. doi:10.1073/pnas.070550797 (Pubitemid 30183329)
40. Srivastava PK. Do human cancers express shared protective antigens? or the necessity of remembrance of things past. Semin Immunol 1996; 8: 295-302. doi:10.1006/smim.1996.0038
41. Nishikawa M, Takemoto S, Takakura Y. Heat shock protein derivatives for delivery of antigens to antigen presenting cells. Int J Pharmaceutics 2008; 354: 23-27. doi:10.1016/j. ijpharm.2007.09.030
42. Wells AD, Rai SK, Salvato MS et al. Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol1998; 10: 609-617. doi:10.1093/intimm/10.5.609
43. Ito A, Shinkai M, Honda H et al. Augmentation of MHC Class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50: 515-522. doi:10.1007/s00262-001-0233-7
44. Vabulas RM, Ahmad-Nejad P, Ghose S et al. Hsp70 as endogenous stimulus of the Toll/Interleukin-1 receptor signal pathway. J Biol Chem 2002; 277: 15107-15112. doi:10.1074/jbc.M111204200
45. Retzlaff C, Yamamoto Y, Hoffman PS et al. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun 1994; 62: 5689-5693.
46. Retzlaff C, Yamamoto Y, Okubo S et al Legionella pneumophila.a heart shock protein-induced increase of interleukin-1 mRNA involves protein kinase C signaling in macrophages. Immunology 1996; 89: 281-288. doi:10.1046/j.1365-2567. 1996.d01-735.x
47. Roskrow MA, Dillow D, Suzuki N et al. Autoimmune disease induced by dendritic cell immunization against leukemia. Leuk Res 1999; 23: 549-557. doi:10.1016/S0145-2126(99)00045-4